Electrical storms in an ICD-recipient with 429 delivered appropriate shocks: Therapeutic management with antiarrhythmic drug combination

被引:14
作者
Manolis, AG [1 ]
Katsivas, AG [1 ]
Vassilopoulos, C [1 ]
Tsatiris, CG [1 ]
机构
[1] Hellen Red Cross Hosp Athens, Athens, Greece
关键词
electrical storm; ICD; antiarrhythmic drugs;
D O I
10.1023/A:1014188526158
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The case of a 65 year old man with ischemic cardiomyopathy, an ICD device and recurrent electrical storms is presented. The patient had been implanted with an ICD device due to aborted sudden death. The first electrical storm occured 12 months later. It was terminated by the administration of intravenous amiodarone and the patient was discharged on maintenance dose amiodarone and b-blocker. After a period of 3 months during which the patient remained asymptomatic, a second arrhythmic clustering occured and it was controlled by the addition of mexiletine. A total number of 429 appropriate shocks had been delivered by the device. Thereafter and for a seven month follow-up period, the patient remains asymptomatic under this combination of antiarrhythmic drugs.
引用
收藏
页码:91 / 94
页数:4
相关论文
共 11 条
[1]   Preferential action of mexiletine on central common pathway of reentrant ventricular tachycardia [J].
Aizawa, Y ;
Abe, A ;
Ohira, K ;
Furushima, H ;
Chinushi, M ;
Fujita, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (07) :1759-1764
[2]   Electrical storm in patients with transvenous implantable cardioverter-defibrillators - Incidence, management and prognostic implications [J].
Credner, SC ;
Klingenheben, T ;
Mauss, O ;
Sticherling, C ;
Hohnloser, SH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) :1909-1915
[3]   Relation between amiodarone and desethylamiodarone plasma concentrations and ventricular defibrillation energy requirements [J].
Daoud, EG ;
Man, KC ;
Horwood, L ;
Morady, F ;
Strickberger, SA .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (01) :97-&
[4]   Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction [J].
Gottlieb, SS ;
McCarter, RJ ;
Vogel, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (08) :489-497
[5]   AMIODARONE-ASSOCIATED PROARRHYTHMIC EFFECTS - A REVIEW WITH SPECIAL REFERENCE TO TORSADE-DE-POINTES TACHYCARDIA [J].
HOHNLOSER, SH ;
KLINGENHEBEN, T ;
SINGH, BN .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (07) :529-535
[6]   EFFECTS OF CHRONIC AMIODARONE THERAPY ON DEFIBRILLATION THRESHOLD [J].
JUNG, W ;
MANZ, M ;
PIZZULLI, L ;
PFEIFFER, D ;
LUDERITZ, B .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (11) :1023-1027
[7]   RANDOMIZED, DOUBLE-BLIND COMPARISON OF INTRAVENOUS AMIODARONE AND BRETYLIUM IN THE TREATMENT OF PATIENTS WITH RECURRENT, HEMODYNAMICALLY DESTABILIZING VENTRICULAR-TACHYCARDIA OR FIBRILLATION [J].
KOWEY, PR ;
LEVINE, JH ;
HERRE, JM ;
PACIFICO, A ;
LINDSAY, BD ;
PLUMB, VJ ;
JANOSIK, DL ;
KOPELMAN, HA ;
SCHEINMAN, MM .
CIRCULATION, 1995, 92 (11) :3255-3263
[8]   DOSE-RANGING STUDY OF INTRAVENOUS AMIODARONE IN PATIENTS WITH LIFE-THREATENING VENTRICULAR TACHYARRHYTHMIAS [J].
SCHEINMAN, MM ;
LEVINE, JH ;
CANNOM, DS ;
FRIEHLING, T ;
KOPELMAN, HA ;
CHILSON, DA ;
PLATIA, EV ;
WILBER, DJ ;
KOWEY, PR .
CIRCULATION, 1995, 92 (11) :3264-3272
[9]   A PROSPECTIVE COMPARISON OF CLASS-IA, CLASS-B, AND CLASS-C ANTIARRHYTHMIC AGENTS IN COMBINATION WITH AMIODARONE IN PATIENTS WITH INDUCIBLE, SUSTAINED VENTRICULAR-TACHYCARDIA [J].
TOIVONEN, L ;
KADISH, A ;
MORADY, F .
CIRCULATION, 1991, 84 (01) :101-108
[10]   COMBINED MEXILETINE AND AMIODARONE TREATMENT OF REFRACTORY RECURRENT VENTRICULAR TACHYCARDIA [J].
WALEFFE, A ;
MARYRABINE, L ;
LEGRAND, V ;
DEMOULIN, JC ;
KULBERTUS, HE .
AMERICAN HEART JOURNAL, 1980, 100 (06) :788-793